UnitedHealth Group Price To Sales Ratio Over Time
| UNH Stock | USD 590.87 6.62 1.11% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out UnitedHealth Group Performance and UnitedHealth Group Correlation. UnitedHealth |
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of UnitedHealth Group. If investors know UnitedHealth will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about UnitedHealth Group listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.043 | Dividend Share 7.96 | Earnings Share 15.36 | Revenue Per Share 427.221 | Quarterly Revenue Growth 0.092 |
The market value of UnitedHealth Group is measured differently than its book value, which is the value of UnitedHealth that is recorded on the company's balance sheet. Investors also form their own opinion of UnitedHealth Group's value that differs from its market value or its book value, called intrinsic value, which is UnitedHealth Group's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because UnitedHealth Group's market value can be influenced by many factors that don't directly affect UnitedHealth Group's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between UnitedHealth Group's value and its price as these two are different measures arrived at by different means. Investors typically determine if UnitedHealth Group is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, UnitedHealth Group's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Price To Sales Ratio Analysis
Compare UnitedHealth Group and related stocks such as Cigna Corp, Humana Inc, and Elevance Health Price To Sales Ratio Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CI | 0.4118 | 0.5168 | 0.5229 | 0.7546 | 0.7778 | 0.9896 | 0.8587 | 1.1785 | 0.9645 | 0.5 | 0.4732 | 0.4453 | 0.5678 | 0.4509 | 0.48 |
| ELV | 0.3808 | 0.3698 | 0.3017 | 0.381 | 0.4558 | 0.4597 | 0.4462 | 0.64 | 0.7251 | 0.7405 | 0.6608 | 0.8151 | 0.7862 | 0.6492 | 0.46 |
| CNC | 0.0769 | 0.3721 | 0.2437 | 0.2937 | 0.3648 | 0.3444 | 0.2221 | 0.3597 | 0.3742 | 0.3483 | 0.3083 | 0.3812 | 0.3263 | 0.2618 | 0.42 |
| MOH | 2.1533 | 0.2142 | 0.2082 | 0.2426 | 0.2603 | 0.2222 | 0.1685 | 0.216 | 0.41 | 0.5015 | 0.646 | 0.662 | 0.5969 | 0.6182 | 0.58 |
| CVS | 0.8622 | 0.5095 | 0.4991 | 0.6871 | 0.8023 | 0.7131 | 0.4769 | 0.4002 | 0.3515 | 0.3764 | 0.3327 | 0.4658 | 0.3801 | 0.2836 | 0.27 |
| ALHC | 4.2825 | 4.2825 | 4.2825 | 4.2825 | 4.2825 | 4.2825 | 4.2825 | 4.2825 | 4.2825 | 4.2825 | 3.3795 | 2.0704 | 1.4859 | 0.8792 | 0.84 |
UnitedHealth Group and related stocks such as Cigna Corp, Humana Inc, and Elevance Health Price To Sales Ratio description
Price to Sales Ratio is figured by comparing UnitedHealth Group stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on UnitedHealth Group sales, a figure that is much harder to manipulate than other UnitedHealth Group Incorporated multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.My Equities
My Current Equities and Potential Positions
| UnitedHealth Group Incorporated | UNH |
| Classification | Obamacare Repeal |
| Location | Minnesota; U.S.A |
| Exchange | New York Stock Exchange |
USD 590.87
Check out UnitedHealth Group Performance and UnitedHealth Group Correlation. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
UnitedHealth Group technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.